Christopher M. Lauderback

Christopher Lauderback is the Senior Vice President of Manufacturing at KemPharm. Prior to this, they were with Sigma-Tau Pharmaceuticals, Inc. from January 2009 to September 2012 as Senior Manager of CMC. Before that, they were with Airbase Therapeutics, LLC from March 2008 to June 2009 as Director of Product Development. Christopher was with New River Pharmaceuticals from July 2001 to October 2007 as Associate Director of CMC Development.

Lauderback received their PhD in Chemistry from the University of Kentucky and their BS in Chemistry from Emory & Henry College.

They work with Sven Guenther - Executive Vice President, Research and Development, Rene A. Braeckman - Vice President, Clinical Development, and R. Laduane Clifton - Chief Financial Officer, Secretary and Treasurer. Their manager is Travis C. Mickle, Co-Founder, Chairman, President & CEO.